National PROspective Infrastructure for Renal Cell Carcinoma (PRO-RCC)
Recruiting
Observational Study
Renal Cancer
Renal Cell Carcinoma
Renal Cell Cancer Metastatic
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 2,000 (estimated)
- Sponsor
- PROspective Renal Cancer Cohort Foundation · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
PRO-RCC is a nationwide long-term cohort for the collection of real-world clinical data, patient reported outcome measures (PROMs) and patient reported experience measures (PREMs) that provides an infrastructure for observational research and (randomized) interventional studies with the TwiCs (Trial within cohorts) design.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* newly diagnosed patients with RCC or synchronous metastatic RCC
* metachronous metastasized RCC
* age \>18 years
* capable of understanding Dutch language
Exclusion Criteria:
* n/a
Contacts